Key Takeaways
- • Even Healthcare raises Rs 208.24 crore ($22 million) in Series B funding led by Khosla Ventures, valuing the company at $300 million post-money, marking the second institutional funding round in 2026.
- • Khosla Ventures commits Rs 145 crore as lead investor, with co-investors DLB Ventures (Rs 38.88 crore) and Simon Fiduciaria (Rs 22.67 crore) participating in the round.
- • The Bengaluru-based subscription-based healthcare platform builds on previous Series A momentum, where Khosla Ventures led a $30 million round, demonstrating sustained investor confidence in the membership model.
- • Series B capital will support Even Healthcare's expansion of its direct-to-consumer healthcare membership offering, reinforcing the venture's positioning in India's digital health infrastructure.
Summary
Even Healthcare, a Bengaluru-based subscription-based healthcare provider, has secured Rs 208.24 crore (approximately $22 million) in Series B funding led by returning investor Khosla Ventures. The round values the company at $300 million, according to regulatory filings dated August 29, 2026. Khosla Ventures anchors the round with a principal investment of Rs 145 crore, while secondary investors DLB Ventures and Simon Fiduciaria contribute Rs 38.88 crore and Rs 22.67 crore, respectively, with participation from ADBEEV LLP rounding out the investor consortium.
The Series B round represents the second major institutional funding event for Even Healthcare in 2026, building on the company's Series A success. Khosla Ventures previously led Even's Series A round, which brought $30 million in capital and established the venture capital firm as a strategic anchor investor in the platform's growth trajectory. The consistency of Khosla's participation across rounds signals confidence in Even Healthcare's membership-based model and its ability to scale within India's evolving digital health ecosystem.
Even Healthcare operates as a membership-based healthcare platform targeting direct-to-consumer subscription models, positioning itself within India's broader shift toward preventive and accessible healthcare delivery. The Series B capital injection is expected to fund platform expansion, user acquisition, and service offerings that reinforce the company's competitive positioning in the subscription healthcare segment. The $300 million valuation reflects investor appetite for digital health infrastructure plays in India's underserved healthcare market, particularly models that combine direct consumer engagement with membership economics.
The Series B round represents the second major institutional funding event for Even Healthcare in 2026, building on the company's Series A success. Khosla Ventures previously led Even's Series A round, which brought $30 million in capital and established the venture capital firm as a strategic anchor investor in the platform's growth trajectory. The consistency of Khosla's participation across rounds signals confidence in Even Healthcare's membership-based model and its ability to scale within India's evolving digital health ecosystem.
Even Healthcare operates as a membership-based healthcare platform targeting direct-to-consumer subscription models, positioning itself within India's broader shift toward preventive and accessible healthcare delivery. The Series B capital injection is expected to fund platform expansion, user acquisition, and service offerings that reinforce the company's competitive positioning in the subscription healthcare segment. The $300 million valuation reflects investor appetite for digital health infrastructure plays in India's underserved healthcare market, particularly models that combine direct consumer engagement with membership economics.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.